Sarcoma  >>  gemcitabine  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
NCT00614835: Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Completed
N/A
25
US
Docetaxel plus Gemcitabine
Memorial Sloan Kettering Cancer Center
Uterine Leiomyosarcoma, Uterine Cancer
02/06
01/12
NCT00673179: Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy

Terminated
N/A
7
US
Doxorubicin, AD, Hydroxydaunomycin hydrochloride, Cisplatin, Paraplatin®, Methotrexate, Leucovorin, Dexrazoxane, Zinecard, Ifosfamide, Ifex, Questionnaire, Survey, Gemcitabine, Gemzar, Gemcitabine Hydrochloride, Sargramostim, GM-CSF, Leukine™, Surgery, Mesna, Mesnex
M.D. Anderson Cancer Center
Osteosarcoma
11/10
11/10
NCT01958580: Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Terminated
N/A
3
US
Gemcitabine Hydrochloride, Difluorodeoxycytidine (dFdC), dFdCyd, Docetaxel, TXT, Internal Radiation Therapy, Brachytherapy, Internal Radiation, Internal Radiation Brachytherapy, Radiation Brachytherapy, Intensity-Modulated Radiation Therapy, IMRT, Intensity Modulated RT, Intensity-Modulated Radiotherapy, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam RT, Laboratory Biomarker Analysis
Albert Einstein College of Medicine, National Cancer Institute (NCI)
Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma, Stage IIA Uterine Sarcoma, Stage IIB Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Corpus Leiomyosarcoma
02/17
02/17
NCT04651179: Study of Effectiveness of GEMDOX in Relapsed Osteosarcoma

Completed
N/A
33
Europe
observation
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Osteosarcoma Recurrent, Osteosarcoma Metastatic
06/21
11/21
ChiCTR2000030250: Phase II clinical trial of albumin-bound paclitaxel plus gemcitabine in the treatment of metastatic/locally unresectable soft tissue sarcoma: a single-center, open, single-arm study

Recruiting
N/A
35
 
albumin-bound paclitaxel plus gemcitabine
Department of Orthopedics, the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital; The Affiliated Cancer Hospital of Zhengzhou University, self-raised
Soft tissue sarcoma
 
 
ChiCTR2000036618: Precision therapy strategy for osteosarcoma based on molecular typing: a prospective, single-center, one-brachial umbrella phase II exploratory clinical study

Not yet recruiting
N/A
18
 
Everolimus 5mg qd + Anlotinib 8mg-12mg day 1-21，28-day cycle ;Camrelizumab 3mg/kg + Ipilimumab 1 mg/kg, 21-days cycle ;Palbociclib 125mg day 1-21 + gemcitabine 600mg/m2 day 1,8,15,22, 28-days cycle ;Olaparib 300mg bid day 1-14 + gemcitabine 600mg/m2 day 1,8,15,22, 28-days cycle ;Metformin 2000mg qd + gemcitabine 675mg/m2 day 1,8, docetaxol 900mg/m2 day 8， 21-days cycle
Shanghai General Hospital; Shanghai General Hospital, Project special fund
osteosarcoma
 
 

Download Options